ESG NOW intro episode 200
Medicine, Chocolate and the ESG Data-verse
One well-worn critique of ESG investing is that some companies with a high rating aren’t actually making the world a better place. We break down this conflation of ESG impact with financial risk by looking at the different sides of J&J and Nestle.
Social Sharing
ESG NOW: Episode 200
Medicine, Chocolate and the ESG Data-verse
十一月 11, 2022
MSCI ESG Now: Episode 199
ep200-featuring
Subscribe to Our Podcast:
Follow our Podcast:
ESG Now Podcast platforms
Medicine, Chocolate and the ESG Data-verse
ESG Now Podcast
ESG explored. A rotating cast of researchers on environmental, social, and governance issues join hosts Mike Disabato and Bentley Kaplan as they discuss the most pressing news of the week. But in an enjoyable way.
Previous episodesChildren in the Cocoa Fields
We begin this episode with an update on the invasion of Ukraine by Russia. Western companies have begun an exodus from Russia as sanctions and atrocities mount. Yet, some are deciding to stay.
Read moreVaccines over Viagra?
Vaccines over Viagra? Health care companies may be incentivized toward neglected public health priorities in the #postCOVID19 world.
Learn more